Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder

NCT00383786 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
47
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Baylor College of Medicine

Collaborators